IL-2/CD25: A long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2R on regulatory T cells

Low-dose IL-2 represents an immunotherapy to selectively expand regulatory T cells (Tregs) to promote tolerance in patients with autoimmunity. Here we show that a fusion protein (FP) of mouse IL-2 and mouse IL-2Rα (CD25), joined by a non-cleavable linker, has greater in vivo efficacy than recombinan...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunol
Main Authors: Ward, Natasha C., Yu, Aixin, Moro, Alejandro, Ban, Yuguang, Chen, Xi, Hsiung, Sunnie, Keegan, James, Arbanas, Jaren M., Loubeau, Martine, Thankappan, Anil, Yamniuk, Aaron P., Davis, Jonathan H., Struthers, Mary, Malek, Thomas R.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200646/
https://ncbi.nlm.nih.gov/pubmed/30282751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800907
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares